Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome

被引:9
作者
Liu, Chi [1 ,2 ]
Zhao, Qi [1 ,2 ]
Zhao, Ziwei [1 ,2 ]
Ma, Xiaoteng [1 ,2 ]
Xia, Yihua [1 ,2 ]
Sun, Yan [1 ,2 ]
Zhang, Dai [1 ,2 ]
Liu, Xiaoli [1 ,2 ]
Zhou, Yujie [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Clin Ctr Coronary Heart Dis, Beijing Key Lab Precis Med Coronary Atherosclerot, Beijing, Peoples R China
关键词
estimated glucose disposal rate; non-ST-segment elevation acute coronary syndrome; percutaneous coronary intervention; insulin resistance; in-stent restenosis; CARDIOVASCULAR-DISEASE INCIDENCE; INSULIN-RESISTANCE; BALLOON ANGIOPLASTY; METABOLIC SYNDROME; TASK-FORCE; PREDICTORS; ATHEROSCLEROSIS; IMPLANTATION; 10-YEAR; HYPERLEPTINEMIA;
D O I
10.3389/fendo.2022.1033354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Insulin resistance (IR) is closely associated with in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). Nevertheless, the predictive power of the newly developed simple assessment method for IR, estimated glucose disposal rate (eGDR), for ISR after PCI in individuals with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains unclear. Methods: NSTE-ACS cases administered PCI in Beijing Anzhen Hospital between January and December 2015 were enrolled. The included individuals were submitted to at least one coronary angiography within 48 months after discharge. Patients were assigned to 2 groups according to ISR occurrence or absence. eGDR was derived as 21.16 - (0.09 * waist circumference [cm]) - (3.41 * hypertension) - (0.55 * glycated hemoglobin [%]). Multivariate logistic regression analysis and receiver operating characteristic (ROC) curve analysis were performed for evaluating eGDR's association with ISR. Results: Based on eligibility criteria, 1218 patients were included. In multivariate logistic analysis, the odds ratios (ORs) of eGDR as a nominal variate and a continuous variate were 3.393 (confidence interval [CI] 2.099 - 5.488, P < 0.001) and 1.210 (CI 1.063 - 1.378, P = 0.004), respectively. The incremental effect of eGDR on ISR prediction based on traditional cardiovascular risk factors was reflected by ROC curve analysis (AUC: baseline model + eGDR 0.644 vs. baseline model 0.609, P for comparison=0.013), continuous net reclassification improvement (continuous-NRI) of -0.264 (p < 0.001) and integrated discrimination improvement (IDI) of 0.071 (p = 0.065). Conclusion: In NSTE-ACS cases administered PCI, eGDR levels show an independent negative association with increased ISR risk.
引用
收藏
页数:12
相关论文
共 48 条
[1]   Current Treatment of In-Stent Restenosis [J].
Alfonso, Fernando ;
Byrne, Robert A. ;
Rivero, Fernando ;
Kastrati, Adnan .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (24) :2659-2673
[3]   RESTENOSIS AFTER TRANSLUMINAL CORONARY ANGIOPLASTY - A RISK FACTOR-ANALYSIS [J].
ARORA, RR ;
KONRAD, K ;
BADHWAR, K ;
HOLLMAN, J .
CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1990, 19 (01) :17-22
[4]   Predictors of restenosis after coronary stent implantation [J].
Bauters, C ;
Hubert, E ;
Prat, A ;
Bougrimi, K ;
Van Belle, E ;
McFadden, EP ;
Amouyel, P ;
Lablanche, JM ;
Bertrand, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (06) :1291-1298
[5]  
Bernat R, 2012, COLLEGIUM ANTROPOL, V36, P1385
[6]   Insulin resistance and coronary artery disease [J].
Bressler, P ;
Bailey, SR ;
Matsuda, M ;
DeFronzo, RA .
DIABETOLOGIA, 1996, 39 (11) :1345-1350
[7]   Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography [J].
Cassese, Salvatore ;
Byrne, Robert A. ;
Tada, Tomohisa ;
Pinieck, Susanne ;
Joner, Michael ;
Ibrahim, Tareq ;
King, Lamin A. ;
Fusaro, Massimiliano ;
Laugwitz, Karl-Ludwig ;
Kastrati, Adnan .
HEART, 2014, 100 (02) :153-159
[8]   Type 1 diabetes, metabolic syndrome and cardiovascular risk [J].
Chillaron, Juan J. ;
Flores Le-Roux, Juana A. ;
Benaiges, David ;
Pedro-Botet, Juan .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (02) :181-187
[9]   Estimated Glucose Disposal Rate in Assessment of the Metabolic Syndrome and Microvascular Complications in Patients with Type 1 Diabetes [J].
Chillaron, Juan J. ;
Goday, Alberto ;
Flores-Le-Roux, Juana A. ;
Benaiges, David ;
Carrera, Maria J. ;
Puig, Jaume ;
Cano-Perez, Juan F. ;
Pedro-Botet, Juan .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3530-3534
[10]   Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes [J].
Cho, Young-Rak ;
Ann, Soe Hee ;
Won, Ki-Bum ;
Park, Gyung-Min ;
Kim, Yong-Giun ;
Yang, Dong Hyun ;
Kang, Joon-Won ;
Lim, Tae-Hwan ;
Kim, Hong-Kyu ;
Choe, Jaewon ;
Lee, Seung-Whan ;
Kim, Young-Hak ;
Kim, Shin-Jae ;
Lee, Sang-Gon .
SCIENTIFIC REPORTS, 2019, 9 (1)